Winton Group’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-10,688
| Closed | -$42K | – | 1073 |
|
|
2021
Q4 | $42K | Sell |
10,688
-101,432
| -90% | -$399K | ﹤0.01% | 982 |
|
|
2021
Q3 | $539K | Sell |
112,120
-36,182
| -24% | -$174K | 0.03% | 825 |
|
|
2021
Q2 | $681K | Sell |
148,302
-15,367
| -9% | -$70.6K | 0.04% | 745 |
|
|
2021
Q1 | $961K | Sell |
163,669
-29,221
| -15% | -$172K | 0.05% | 485 |
|
|
2020
Q4 | $660K | Sell |
192,890
-182,273
| -49% | -$624K | 0.05% | 639 |
|
|
2020
Q3 | $540K | Buy |
375,163
+40,452
| +12% | +$58.2K | 0.02% | 1081 |
|
|
2020
Q2 | $668K | Buy |
334,711
+169,000
| +102% | +$337K | 0.02% | 1119 |
|
|
2020
Q1 | $323K | Buy |
+165,711
| New | +$323K | 0.01% | 1152 |
|
|
2019
Q4 | – | Sell |
-23,838
| Closed | -$72K | – | 1677 |
|
|
2019
Q3 | $72K | Buy |
+23,838
| New | +$72K | ﹤0.01% | 1480 |
|